Ryan P. Grimsland

CFO

Chief Financial Officer

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 1 buy · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€7,578

▼ Sales (0 ops.)

—

Latest filing published 17 Mar 2026 for Advance Auto Parts INC, €33k. Read the official filing

Filing timeline

BuySale

Ryan P. Grimsland

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

100%

T+90 mean return

+62.2%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Ryan P. Grimsland: trading record in brief

This profile gathers the share dealings of Ryan P. Grimsland in Advance Auto Parts Inc, where the filings describe the role as finance chief. The record holds 10 filings, for trades running from 4 December 2023 to 14 March 2026.

On the market, this insider has only ever bought: 1 purchase, €7,578 in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 9 share grants.

Most recently, on 17 March 2026, the filings show a share grant worth €33k in Advance Auto Parts Inc. The most recent open-market purchase was published on 31 March 2025, 566 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.